sulfadiazine has been researched along with ketoconazole in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.69) | 18.7374 |
| 1990's | 2 (15.38) | 18.2507 |
| 2000's | 4 (30.77) | 29.6817 |
| 2010's | 6 (46.15) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Doman, TN; McGovern, SL; Seidler, J; Shoichet, BK | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Alves, AJ; Alves, AQ; Alves, EW; Carvalho, CS; de Aquino, TM; de Araújo, JM; de Faria, AR; de Lima, JG; de Melo, EJ; Góes, AJ; Liesen, AP; Lima, VT | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Chretien, JH; Garagusi, VF | 1 |
| Barraviera, B; Castilho, LM; Curi, PR; Da Silva, CL; Foss, NT; Marcondes-Machado, J; Meira, DA; Mendes, RP; Pellegrino Júnior, J; Peracoli, MT; Pereira, PC; Rezkallah-Iwasso, MT; Thomazini, I | 1 |
| Dupont, B | 1 |
| Andrade, DR; Barone, AA; Benard, G; Del Negro, GM; Gryschek, RC; Higaki, Y; Hoo, S; Segurado, AA; Shikanai-Yasuda, MA; Vaccari, EH | 1 |
| Fontes, CJ; Menezes, VM; Soares, BG | 1 |
4 review(s) available for sulfadiazine and ketoconazole
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Current management of fungal enteritis.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Diarrhea; Enteritis; Histoplasmosis; Humans; Imidazoles; Immunosuppression Therapy; Ketoconazole; Miconazole; Mycoses; Neoplasms; Nystatin; Paracoccidioidomycosis; Piperazines; Sulfadiazine | 1982 |
[Exotic pulmonary mycoses].
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Anti-Infective Agents; Antifungal Agents; Blastomycosis; Coccidioidomycosis; Diagnosis, Differential; Histoplasmosis; Humans; Itraconazole; Ketoconazole; Lung Diseases, Fungal; Paracoccidioidomycosis; Penicillium; Sporotrichosis; Sulfadiazine; Travel; Trimethoprim, Sulfamethoxazole Drug Combination | 1998 |
Drugs for treating paracoccidioidomycosis.
Topics: Antifungal Agents; Humans; Itraconazole; Ketoconazole; Paracoccidioidomycosis; Randomized Controlled Trials as Topic; Sulfadiazine | 2006 |
2 trial(s) available for sulfadiazine and ketoconazole
| Article | Year |
|---|---|
The use of glucan as immunostimulant in the treatment of paracoccidioidomycosis.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Aged; Amphotericin B; Anti-Infective Agents; Antibodies, Fungal; Antifungal Agents; beta-Glucans; Blood Sedimentation; CD3 Complex; CD4 Antigens; CD4 Lymphocyte Count; CD4-CD8 Ratio; CD8 Antigens; Drug Therapy, Combination; Glucans; Humans; Immunization; Ketoconazole; Male; Middle Aged; Paracoccidioides; Paracoccidioidomycosis; Phytohemagglutinins; Skin Tests; Sulfadiazine; Sulfanilamides; T-Lymphocyte Subsets; Trimethoprim, Sulfamethoxazole Drug Combination; Tumor Necrosis Factor-alpha | 1996 |
Randomized trial with itraconazole, ketoconazole and sulfadiazine in paracoccidioidomycosis.
Topics: Adolescent; Adult; Antifungal Agents; Female; Humans; Itraconazole; Ketoconazole; Male; Middle Aged; Paracoccidioidomycosis; Sulfadiazine; Treatment Outcome | 2002 |
7 other study(ies) available for sulfadiazine and ketoconazole
| Article | Year |
|---|---|
Identification and prediction of promiscuous aggregating inhibitors among known drugs.
Topics: Antifungal Agents; beta-Lactamase Inhibitors; Chemical Phenomena; Chemistry, Physical; Chymotrypsin; Enzyme Inhibitors; Kinetics; Light; Malate Dehydrogenase; Models, Molecular; Molecular Conformation; Scattering, Radiation; Structure-Activity Relationship | 2003 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Synthesis and evaluation of anti-Toxoplasma gondii and antimicrobial activities of thiosemicarbazides, 4-thiazolidinones and 1,3,4-thiadiazoles.
Topics: Animals; Anti-Infective Agents; Antiprotozoal Agents; Bacteria; Chlorocebus aethiops; Drug Resistance; Fungi; Intracellular Space; Microbial Sensitivity Tests; Semicarbazides; Thiazolidines; Toxoplasma; Vero Cells | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |